Hepatic injury signals drive proteomic reprogramming of the mesenchymal stem cells secretome to counteract liver damage
Abstract
Abstract Paracetamol (APAP) overdose remains a leading cause of acute liver failure (ALF), a life-threatening condition with limited therapeutic options. The secretome of mesenchymal stem cells (MSCs) contain immunomodulatory and pro-regenerative factors that promote endogenous liver regeneration in ALF. In vivo , MSCs respond dynamically to injury microenvironments, adapting their paracrine activity to counteract damage. Accordingly, in vitro priming has been explored to reproduce injury-associated cues to enhance MSC therapeutic efficacy. This study aimed at uncovering the regenerative response of MSCs to hepatic pathological conditions, in specific to hepatic injury-associated signals. Human neonatal MSCs (hnMSCs) were primed with SOS signals from APAP-injured HepG2 cells. The resulting secretome (CM-pMSC) was analyzed for proteomic composition and evaluated for biological activity in APAP-injured hepatocyte-like cells (HLCs). CM-pMSC significantly increased APAP-injured HLCs viability, reduced reactive oxygen species, recovered APAP-impaired urea production and restored HLCs’ gene expression of proliferation- and APAP toxicity-related genes, namely ccnd1 , wnt2 , cyp2e1 , ask1 and gss . Proteomic analysis revealed that CM-pMSC was enriched in proteins associated with response to stress, immunoregulation, extracellular matrix (ECM) organization and metabolism regulation. This included proteins involved in key phases of hepatocyte proliferation, e.g. , IL-6, HGF, TGF-β1,…
How strong is the evidence?
Evidence Hub reads this as a preprint, done in cell cultures (in vitro), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial
- Effect of a Postoperative Multimodal Opioid-Sparing Protocol vs Standard Opioid Prescribing on Postoperative Opioid Consumption After Knee or Shoulder Arthroscopy: A Randomized Clinical Trial
- Comparison of the Post-Caesarean Analgesic Effect of Adding Dexmedetomidine to Paracetamol and Ketorolac: A Randomized Clinical Trial
- A triple-blind randomized clinical trial of different associations between dexamethasone and non-steroids anti-inflammatories for preemptive action in third molar extractions
- An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
- Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: Single centre double-blind, randomised controlled clinical trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.